https://www.hcplive.com/view/long-acting-insulin-analogues-reduce-mace-risk-patients-t2d
0
0
8/17/22 at 7:36pm
Organization
Hcplive.com
Author
Connor Iapoce
32 words
0
Comments
Glargine and detemir insulin were modestly associated with a reduced risk of MACE compared to neutral protamine Hagedorn insulin.
You are the first to view
Create an account
or login to join the discussion